DEPO Depomed, Inc. (delisted)

Depomed, Inc. (NASDAQ:DEPO) today announced that senior management will present at the following healthcare conferences during the month of March.

29th Annual ROTH Conference

Date: Monday, March 13, 2017 Time: 3:00 p.m. PDT Location: Dana Point, California

Oppenheimer 27th Annual Healthcare Conference

Date: Tuesday, March 21, 2017 Time: 8:30 a.m. EDT Location: New York, New York

These presentations will be webcast live and may be accessed via the Investor Relations page of the Depomed website at www.depomed.com.  A recording of these events will be archived for 30 days on the company's website.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com.

Investor Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
ckeenan@depomed.com